Editorial
Autoinflammatory syndromes
M. Galeazzi, G. Gasbarrini, A. Ghirardello, S. Grandemange, H.M. Hoffman, R. Manna, M. Podswiadek, L. Punzi, G.D. Sebastiani, I. Touitou, A. Doria
CER2713
2006 Vol.24, N°1 ,Suppl.40
PI 0079, PF 0085
Editorial
Free to view
(click on article PDF icon to read the article)
PMID: 16513033 [PubMed]
Abstract
ABSTRACT: The autoinflammatory disorders are a new and expanding classification of inflammatory diseases characterized by recurrent episodes of systemic inflammation in the absence of pathogens, autoantibodies or antigen specific T cells. These disorders are caused by primary dysfunction of the innate immune system, without evidence of adaptive immune dysregulation.Innate immune abnormalities include aberrant responses to pathogen associated molecular patterns (PAMPs) like lipopolysaccharide and peptidoglycan, prominent neutrophilia in blood and tissues, and dysregulation of inflammatory cytokines (IL-1&bgr;, TNF-α) or their receptors.The autoinflammatory diseases comprise both hereditary (Familial Mediterranean Fever, FMF; Mevalonate Kinase Deficiency, MKD; TNF Receptor Associated Periodic Syndrome, TRAPS; Cryopyrin Associated Periodic Syndrome, CAPS; Blau syndrome; Pyogenic sterile Arthritis, Pyoderma gangrenosum and Acne syndrome, PAPA; Chronic Recurrent Multifocal Osteomyelitis, CRMO) and multifactorial (Crohn’s and Behçet’s diseases) disorders. Mutations responsible for FMF, TRAPS, CAPS, PAPA are in proteins involved in modulation of inflammation and apoptosis.
